Home・Listă Acțiuni・Pulse Biosciences Inc

Pulse Biosciences Inc

Închisă

SectorSănătate

40.61 4.4

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

40.61

Maxim

40.71

Indicatori cheie
By Trading Economics
Venit	-1.1M -19M
Vânzări	137K 401K
EPS	-0.241
Marjă de profit	-4,633.666
Angajați	116
EBITDA	-1.7M -19M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	-21.01% downside

Dividende
By Acuity
Următoarele câștiguri	4 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	1.1B 2.6B
Deschiderea anterioară	36.21
Închiderea anterioară	40.61

Sentimentul știrilor

By Acuity

31%

69%

81 / 340 Clasament în Healthcare

Pulse Biosciences Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 aug. 2026, 19:51 UTC

News

Pulse Biosciences shares are higher after reporting second-quarter revenue of $434,000 and increasing patient enrollment targets for its pivotal trial.

6 aug. 2026, 22:16 UTC

News

Pulse Biosciences reported a net loss of $24.7 million for Q2 2026. Shares are trading higher after announcing significant progress in its cardiac catheter program.

5 aug. 2026, 20:06 UTC

Pulse Biosciences Inc shares are lower during Wednesday's trading session, reversing from a recent trend of higher daily closes. No specific news was identified.

3 aug. 2026, 20:03 UTC

Pulse Biosciences Inc shares are higher today, driven by a significant advance in the Health Care Equipment sector and unusually high trading volume.

31 iul. 2026, 19:16 UTC

Pulse Biosciences Inc is gaining during Friday's session, reaching a high above Thursday's close. The stock remains above its 20-day moving average.

30 iul. 2026, 20:09 UTC

Event

Pulse Biosciences' NANOPULSE-AF Study enrollment surpasses midpoint, supporting stock gains since Wednesday. Shares remain above the 20-day moving average amid market volatility.

29 iul. 2026, 22:03 UTC

Event

Pulse Biosciences shares are lower in after-market hours despite surpassing enrollment midpoint in its NANOPULSE-AF Study, reflecting broader cautious market sentiment.

28 iul. 2026, 23:46 UTC

Pulse Biosciences Inc shares are lower in after-market trading, reflecting volatility amid broader market declines, though no specific news was identified.

27 iul. 2026, 19:51 UTC

Pulse Biosciences Inc shares are higher today amid unusually high trading volume, despite earlier downward movement. No specific news was identified to explain the move.

24 iul. 2026, 18:11 UTC

Pulse Biosciences Inc shares are lower today, breaking a trend of higher daily closes. The stock is trading with unusually high market volume.

22 iul. 2026, 19:31 UTC

Pulse Biosciences shares are higher today amid increased trading volume, despite earlier pulling back from session highs. No specific news was identified to explain the movement.

21 iul. 2026, 22:51 UTC

Pulse Biosciences Inc shares declined in after-market trading, reversing earlier gains. No specific news was identified to explain the price movement.

20 iul. 2026, 19:26 UTC

Shares of Pulse Biosciences Inc. are lower today, reversing earlier gains amid broader market pressure from rising US Treasury yields and geopolitical uncertainties.

Comparație

Modificare preț

Pulse Biosciences Inc Așteptări

Obiectiv de preț

By TipRanks

-21.01% jos

Prognoză pe 12 luni

Medie 33.5 USD -21.01%

Maxim 35 USD

Minim 32 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPulse Biosciences Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 2 analiști care au acordat evaluări ale acțiunilor Pulse Biosciences Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

81 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.